News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
BAKER JULIAN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/22/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/15/2016 |
SC 13D/A
| GENOMIC HEALTH INC reports a 42% stake in Genomic Health, Inc. |
| 08/11/2016 |
SC 13D/A
| GENOMIC HEALTH INC reports a 41.7% stake in Genomic Health, Inc. |
| 05/19/2016 |
SC 13D/A
| GENOMIC HEALTH INC reports a 42.1% stake in Genomic Health, Inc. |
| 03/17/2016 |
SC 13D/A
| BAKER JULIAN reports a 12.7% stake in Incyte Corporation |
| 08/02/2013 |
SC 13D/A
| BAKER JULIAN reports a 11.7% stake in BIOCRYST PHARMACEUTICALS, INC. |
| 06/05/2013 |
SC 13D/A
| GENOMIC HEALTH INC reports a 45.8% stake in Genomic Health, Inc. |
| 07/19/2012 |
SC 13D/A
| BAKER JULIAN reports a 35.3% stake in Synageva BioPharma Corp. |
| 06/21/2012 |
SC 13D/A
| Ardea Biosciences, Inc. reports a 0% stake in Ardea Biosciences, Inc. |
| 05/04/2012 |
SC 13D/A
| BAKER JULIAN reports a 36.1% stake in Synageva BioPharma Corp. |
| 04/23/2012 |
SC 13D/A
| BAKER JULIAN reports a 36.1% stake in Synageva BioPharma Corp. |
| 04/23/2012 |
SC 13D/A
| BAKER JULIAN reports a 15% stake in BIOCRYST PHARMACEUTICALS, INC. |
| 04/23/2012 |
SC 13D/A
| BAKER JULIAN reports a 20% stake in Incyte Corporation |
| 04/23/2012 |
SC 13D/A
| Ardea Biosciences, Inc. reports a 19.5% stake in Ardea Biosciences, Inc. |
| 04/23/2012 |
SC 13D/A
| BAKER JULIAN reports a 18.5% stake in Seattle Genetics, Inc |
| 04/23/2012 |
SC 13D/A
| GENOMIC HEALTH INC reports a 35.2% stake in Genomic Health, Inc |
| 02/16/2012 |
SC 13D/A
| BAKER JULIAN reports a 33.1% stake in Genomic Health, Inc |
| 02/03/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 01/11/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 11/17/2011 |
SC 13D/A
| GENOMIC HEALTH INC reports a 29.2% stake in Genomic Health, Inc |
| 11/09/2011 |
SC 13D/A
| TRIMERIS INC reports a 36.3% stake in Synageva BioPharma Corp. |
| 10/13/2011 |
SC 13D/A
| BIOCRYST PHARMACEUTICALS INC reports a 15.3% stake in BIOCRYST PHARMACEUTICALS, INC. |
| 03/08/2011 |
SC 13D/A
| GENOMIC HEALTH INC reports a 26.3% stake in Genomic Health, Inc |
| 03/02/2011 |
SC 13D/A
| GENOMIC HEALTH INC reports a 25.1% stake in Genomic Health, Inc |
| 01/24/2011 |
SC 13D/A
| Ardea Biosciences, Inc. reports a 23.7% stake in Ardea Biosciences, Inc. |
| 08/13/2010 |
SC 13D/A
| GENOMIC HEALTH INC reports a 22.7% stake in Genomic Health, Inc |
| 02/12/2010 |
SC 13D/A
| Ardea Biosciences, Inc. reports a 28.8% stake in Ardea Biosciences, Inc. |
| 02/10/2010 |
SC 13D/A
| BAKER JULIAN reports a 21.4% stake in Genomic Health, Inc |
| 10/01/2009 |
SC 13D/A
| BAKER JULIAN reports a 20% stake in Incyte Corporation |
| 09/30/2009 |
SC 13D/A
| BAKER JULIAN reports a 20% stake in Incyte Corporation |
| 08/17/2009 |
SC 13D/A
| BAKER JULIAN reports a 20.2% stake in Genomic Health, Inc |
| 03/03/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 12/23/2008 |
SC 13D/A
| BAKER JULIAN reports a 16.1% stake in Incyte Corporation |
| 12/19/2008 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
|
|
|